Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Other Non-Current Liabilities: 2022

Historic Other Non-Current Liabilities for Therapeutics (LENZ) over the last 1 years, with Dec 2022 value amounting to $10.8 million.

  • Therapeutics' Other Non-Current Liabilities was N/A to $871,000 in Q1 2023 from the same period last year, while for Mar 2023 it was $871,000, marking a year-over-year change of. This contributed to the annual value of $10.8 million for FY2022, which is N/A change from last year.
  • Therapeutics' Other Non-Current Liabilities amounted to $10.8 million in FY2022.
  • Therapeutics' 5-year Other Non-Current Liabilities high stood at $10.8 million for FY2022, and its period low was $10.8 million during FY2022.
  • Its 1-year average for Other Non-Current Liabilities is $10.8 million, with a median of $10.8 million in 2022.